通过II型抗CD20治疗抗体Obinutuzumab获得补充依赖的细胞毒性
Alicja Kuźniewska1, Alan Majeranowski1,2, Sara Henry1
1Department of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 Street, 80-211 Gdańsk, Poland.
Cancers
|January 11, 2024
概括
一个C2变种增强了obinutuzumab的功效.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 利图西马布和奥比努图祖马布是抗CD20单克隆抗体 (mAbs),具有不同的补体系统激活能力.
- 这种差异归因于抗原-抗体复合结构,影响C1q参与.
- 奥比努图祖马布激活补充剂的能力不如利图西马布的效率.
研究的目的:
- 为了研究一种功能增益的C2变体是否可以增强奥比努图祖马布的补体激活.
- 评估这种C2变体对由obinutuzumab介导的补充依赖性细胞毒性 (CDC) 的影响.
主要方法:
- 与C2变体和人体血清或全血同时使用奥比努祖马布.
- 对细胞的补充依赖性细胞毒性的测量.
- 在具有不同补体敏感性的细胞中评估长期 (24小时) 细胞毒性.
主要成果:
- 与obinutuzumab同时应用C2变异导致CDC等于或高于rituximab.
- 这种增强观察到的人类血清和hirudin-anticoagulated全血.
- 长期的obinutuzumab细胞毒性在中度敏感细胞中得到改善,但在低敏感细胞中减少.
结论:
- 抗体介导的补体激活在级联的后期阶段是可调节的,不仅仅是由初始抗原相互作用决定的.
- 这种C2变种显著提高了obinutuzumab的CDC潜力.
- 这种增强的效应机制的治疗效益取决于细胞的特征.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cytotoxic T Cells-mediated Immune Response
921
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
T Cell Activation and Clonal Selection
739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
739


